Heart Failure Association of the European Society of Cardiology update on sodium-glucose co-transporter 2 inhibitors in heart failure (an update on the sodium-glucose co-transporter 2 inhibitors in heart failure: beyond glycaemic control. A position paper of the Heart Failure Association of the European Society of Cardiology)

Seferovic P. M., Fragasso G., Petrie M., Mullens W., Ferrari R., Thum T., ...More

EUROPEAN JOURNAL OF HEART FAILURE, vol.22, no.11, pp.1984-1986, 2020 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 22 Issue: 11
  • Publication Date: 2020
  • Doi Number: 10.1002/ejhf.2026
  • Journal Name: EUROPEAN JOURNAL OF HEART FAILURE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, MEDLINE
  • Page Numbers: pp.1984-1986
  • Keywords: Heart failure, Sodium&#8211, glucose co&#8208, transporter 2 inhibitors, Type 2 diabetes mellitus, Cardiovascular outcomes, Renal function
  • Eskisehir Osmangazi University Affiliated: Yes

Abstract

The Heart Failure Association (HFA) of the European Society of Cardiology (ESC) has recently issued a position paper on the role of sodium-glucose co-transporter 2 (SGLT2) inhibitors in heart failure (HF). The present document provides an update of the position paper, based of new clinical trial evidence. Accordingly, the following recommendations are given: